Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

Table 1

Site and number of metastasis in the 59 evaluated patients at the enrollment in the clinical trial.

Site of metastasis	Number of metastasis
	≤5	>5
Bone (21/59)	0/21	21/21
Liver (42/59)	2/42	40/42
Lung (4/59)	0/4	4/4
Lymph nodes (34/59)	3/34	31/34
Other (6/59)	1/6	5/6